Purine nucleoside phosphorylase (PNP) deficiency is an autosomal recessive metabolic disorder characterized by severe combined immunodeficiency and by complex neurologic symptomatology including ataxia, developmental delay, and spasticity. Herein we report severe marrow dysplasia in a patient with PNP deficiency. Drug-related marrow dysfunction was unlikely, and marrow virological studies were negative. A preleukemic myelodysplastic syndrome was also unlikely due to normal marrow CD34ϩ cells, colony growth in clonogenic assay of marrow mononuclear cells, apoptosis rate, and Fas expression on marrow nucleated cells, as well as morphologic improvement of the marrow dysplasia after normal red blood cell transfusion. The patient's marrow stroma showed hypersensitivity to irradiation and undetectable PNP enzyme activity similar to peripheral lymphocytes. This is the first report of PNP deficiency associated with increased lymphocyte and marrow stromal sensitivity to irradiation. We conclude that marrows from patients with PNP deficiency might have hypersensitivity to irradiation and can develop dysplastic morphology, caused either directly or indirectly by the inherited enzymatic defect. The PNP protein reversibly catalyzes the degradation of the purine nucleosides inosine and deoxyinosine to hypoxanthine and guanosine and deoxyguanosine to guanine (3, 4). PNP is highly expressed in lymphoid tissues (2). Abnormal PNP activity results in deoxyguanosine triphosphate accumulation in the mitochondria, which inhibits mitochondrial DNA repair. This leads to increased sensitivity of T lymphocytes to DNA damage and apoptosis during thymus selection (5). PNP is encoded by six exons spanning 9 kb of chromosome 14q13 (6, 7). Relatively few mutations have been reported in PNP deficiency (8 -14), with variable degrees of enzymatic activity, which might in part explain variability in disease course (12, 13, (15) (16) (17) (18) .
PNP deficiency results in severe combined immunodeficiency with profound T-cell abnormalities and variable B-cell function (1, 2) . Patients with PNP deficiency suffer from recurrent bacterial, viral, and fungal infections of varying severity. Infections usually begin early in life, but may appear in late childhood (2) . Other complications include spasticity, mental retardation, and autoimmune diseases. Without bone marrow transplantation, patients with PNP deficiency die from uncontrolled infections or malignancy during their first decade of life (1) .
The PNP protein reversibly catalyzes the degradation of the purine nucleosides inosine and deoxyinosine to hypoxanthine and guanosine and deoxyguanosine to guanine (3, 4) . PNP is highly expressed in lymphoid tissues (2) . Abnormal PNP activity results in deoxyguanosine triphosphate accumulation in the mitochondria, which inhibits mitochondrial DNA repair. This leads to increased sensitivity of T lymphocytes to DNA damage and apoptosis during thymus selection (5) . PNP is encoded by six exons spanning 9 kb of chromosome 14q13 (6, 7) . Relatively few mutations have been reported in PNP deficiency (8 -14) , with variable degrees of enzymatic activity, which might in part explain variability in disease course (12, 13, (15) (16) (17) (18) .
Rare cases of megaloblastoid and dysplastic changes in marrow morphology were reported in PNP deficiency (19, 20) , but these were not further investigated or characterized. Herein we describe for the first time a patient with PNP deficiency, who developed severe trilineage marrow dysplasia. The relationship between PNP deficiency and myelodysplasia is discussed.
infection with pure red cell aplasia at the age of 26 mo and varicella zoster infection at the age of 32 mo. The pure red cell aplasia resolved completely, but later on at the age of 35 mo he suffered severe hemolytic anemia associated with mycoplasma pneumonia infection. He continued to experience intermittent mild to moderate autoimmune hemolytic episodes associated with the development of anti-C3d antibody. In addition, the patient had mild gross motor and speech developmental delay. On physical examination he had no palpable lymph nodes or tonsils, as well as mild ataxia.
The patient's immunologic and genetic studies have been previously reported (14) . In brief, immunologic investigation revealed low lymphocyte count, low CD2 (46%), CD3 (16%), CD4 (13%), CD8 (2%), and abnormally reduced in vitro responses to the mitogens phytohemagglutinin, concavalin A, staphylococcal-antigen Cowan strain I, and staphylococcal protein A. Lymphocyte adenosine deaminase enzyme activity was normal and PNP enzyme activity was undetectable. B-cell function and numbers as measured by immunoglobulin (IgA, IgG, IgM) levels, isohemagglutinins, specific antibody titers to tetanus toxoid, polioviruses 1, 2, and 3, and lymphocyte subpopulations bearing CD19 and CD56 were all normal.
The patient had two novel mutations of the PNP gene. The maternal-derived allele carried a C to T transition in exon 2 resulting in a premature stop codon at amino acid 57. The paternal-derived mutation caused skipping of exon 3, as a result of a G to A transition at position ϩ1 of intron 3 resulting in a reading frameshift and the predicted polypeptide termination at amino acid 89.
A donor for hematopoietic stem cell transplantation was not available. At the age of 8 y the patient developed progressive anemia, erythrocytic macrocytosis, and neutropenia without preceding recent infections. At that time he had been receiving treatment with acyclovir, cotrimoxazole, alternate-day lowdose prednisone, and monthly immunoglobulins. At the age of 8 y and 3 mo he developed recurrent left popliteal deep vein thrombosis, which was treated with enoxaparin, and skin rash.
Laboratory investigation at this stage revealed Hb 89 g/L, mean corpuscular volume 114 fL, reticulocytes 59 ϫ 10 9 /L, and platelets 286 ϫ 10 9 /L. Total white blood cells gradually decreased to 1.6 ϫ 10 9 /L with neutrophils of 0.8 ϫ 10 9 /L, with no blasts, lymphocytes 0.11 ϫ 10 9 /L, monocytes 0.35 ϫ 10 9 /L. His eosinophils, which were low at the stage of the leukopenia, gradually increased to 7.0 ϫ 10 9 /L. Peripheral blood smear showed macrocytic red blood cells. The following tests were within normal limits: serum ferritin; serum B12; red blood cell folate; antineutrophil antibody; antiplatelet antibody; liver and renal function; TSH; antinuclear antibody; antineutrophil cytoplasmic antibody; Ham's test; antithrombin 3; antiphospholipid antibody; protein C; protein S; activated protein C resistance; antiphospholipids; anticardiolipin antibody; prothrombin mutation; factor V Leiden; blood cultures for bacteria, mycobacteria, and fungi; serology for trichinella, toxocara, and mycoplasma; and chest x-ray. Abdominal ultrasound showed mild splenomegaly and a few periportal nodes. Computed tomography of the brain revealed an old infarct in the left caudate nucleus with mild generalized atrophy. Total body gallium scan and echocardiogram were normal.
Bone marrow biopsy and aspirate showed a normocellular specimen with prominent trilineage dysplasia including multinucleated erythroid precursors, granulocytes with bizarre or hypersegmented nuclei, and micromegakaryocytes ( Fig. 1,  A-D) . Immunostaining with an anti-factor VIII antibody showed dysplastic unilobulated megakaryocytes (Fig. 1E) . Eosinophilic hyperplasia with numerous precursors and mature forms were also present. No ring sideroblasts were found on Prussian blue stain. There was no fibrosis or abnormal localization of immature precursors on the biopsy specimen. Marrow cell differential at this stage showed myeloblasts 4%, promyelocytes 5%, myelocytes 14%, metamyelocytes 6%, bands 6%, polymorphonuclear 7%, erythroblasts 42%, eosinophils 12%, lymphocytes 5%. No characteristic findings of parvovirus B19 infection were found at this stage; specifically, there were no signs of pure red cell aplasia and bizarre giant proerythroblasts. Further, PCR of genomic DNA extracted from marrow cells was negative for parvovirus B-19. We used the primers 5' (AGT AAA GAA AGT GGC AAA TGG) 3' and 5' (TAC TAC TTG TGC TTG AAA CCC) 3ϽprimeϾ, which target a region of the VP1 gene highly conserved across all genotypes of parvovirus B-19. The expected size of the amplicon is 576 bp, and its identity is verified by digestion with the restriction enzyme ApaI. PCR was also negative for human herpes virus 1, 2, 6, 7, and 8; Epstein-Barr virus; cytomegalovirus; and varicella zoster virus. In situ hybridization for EBV and cytomegalovirus were negative. Cytogenetic analysis of marrow cells showed 46,XY.
Discontinuation of cotrimoxazole and acyclovir did not improve the cytopenia or the bone marrow morphology. Due to progressive anemia the patient received red blood cell transfusions. Interestingly, 1 wk after red blood cell transfusion (which of course contain PNP) the marrow abnormalities dramatically improved, and only few dysplastic erythroblasts and megakaryocytes could be seen. Marrow cell differential at this stage showed myeloblasts 4%, promyelocytes 4%, myelocytes 25%, metamyelocytes 12%, bands 11%, polymorphonuclear 10%, erythroblasts 24%, eosinophils 8%, and lymphocytes 2%. A month later, during a prolonged illness with herpes zoster, and while on therapeutic blood enoxaparin levels, he developed frontal intracranial hemorrhage and died with progressive cerebral edema and neurologic deterioration despite medical and neurosurgical interventions.
MATERIAL AND METHODS
Electron microscopy. A portion of this bone marrow biopsy was fixed in universal fixative (equal parts of 1% glutaraldehyde and 4% formaldehyde) and postfixed in 1% osmium tetroxide, dehydrated in graded alcohols and propylene oxide, and embedded in Epon. One-micrometer-thick sections were stained with toluidine blue. Ultrathin sections were stained with uranyl acetate and lead citrate, and examined under a JEOL 1230 transmission electron microscope (JEOL, Tokyo, Japan).
Percentage of CD34؉ cells in marrow cell samples. Bone marrow aspirates collected in preservative-free heparin underwent Ficoll (Amersham Pharmacia Biotech AB, Uppsala, Swe- Sensitivity to irradiation. Sensitivity of peripheral blood lymphocytes to irradiation was evaluated using T lymphocytes purified from the patient's and normal control's peripheral blood by Ficoll separation and B-cell rosetting. T cells (1 ϫ 10 6 /mL) were exposed to varying doses of gamma irradiation. The cells were then cultured in 96 flat-bottomed plates in the presence of phytohemagglutinin (5 g/mL) and IL-2 (10 U/mL). Lymphocyte proliferation was measured after 72 h. Eight hours before the termination of the culture, 1 Ci [ 3 H]thymidine was added. All experiments were done in triplicates.
Sensitivity of marrow stromal cells was evaluated using stromal cell layers established as previously published (21) PNP activity of the marrow stroma. PNP enzymatic activity in the marrow stroma of the patient and normal controls was assessed in cell lysates using cellulose TLC with [8- 14 C]inosine (50 mCi/mmol; Moravek Biochemicals, Brea, CA, U.S.A.) as substrate, as described previously (23) .
RESULTS

Electron microscopy.
Ultrastructural evaluation of the erythroblasts shows vacuolization of the nuclear heterochromatin to give an overall spongy "Swiss cheese" appearance, enlargement of the nuclear pores with partial loss of the nuclear envelope, invaginations of cytoplasmic portions into the nuclei of the erythroblasts through the absent areas of the nuclear envelope, and the presence of cytoplasmic myelin-like figures (Fig. 2) . These findings are comparable with those seen in congenital dyserythropoietic anemia type I. There were also pluripolar mitoses, karyorrhexis, and formation of cytoplasmic marginal cisternae as seen in congenital dyserythropoietic anemia type II. Giant multinucleated erythroblasts, nuclear clefts and blebs, and the presence of iron-filled mitochondria as seen in congenital dyserythropoietic anemia type III were not observed.
Percentage of CD34؉ cells in marrow cell samples and clonogenic assays of marrow mononuclear cells. Patients with preleukemic myelodysplastic syndrome may have high percentage of marrow CD34ϩ, which correlates with advanced disease stage. Flow cytometric analysis of post-Ficolled marrow samples using a FITC-conjugated anti-CD34ϩ antibody showed 5% CD34ϩ cells in the patient's marrow, which was comparable to the percentage from 10 normal controls (mean Ϯ SD: 4.4% Ϯ 1.7%).
Clonogenic potential of patients' marrow mononuclear cells was normal: means of duplicate CFU-GM, BFU-E, and CFUmix colonies were 288, 67, and 4, respectively. Means of controls' marrow were 70 -300, 50 -180, and 2-15, respectively. Also, the ratio of cluster-to-colony formation was normal at 0.09 (means of controls: 0.10; range, 0.03-0.18), which is consistent with early, rather than advanced, myelodysplastic syndrome.
Apoptotic rates of hematopoietic progenitor cells and Fas expression. Apoptosis rate of marrow cells was determined by flow cytometry after staining post-Ficoll samples with annexin V and propidium iodide. Apoptotic cells were identified as annexin V-positive, propidium iodide-negative events. Patient's marrow cells showed apoptosis rate of 13%, which was comparable to normal controls (mean Ϯ SD, 17% Ϯ 8%, n ϭ 10). Flow cytometric analysis of post-Ficoll marrow samples using a PE-conjugated anti-Fas antibody showed 3% Fasϩ cells in the patient's marrow, which was in the normal range (mean Ϯ SD, 17% Ϯ 10%, n ϭ 10).
Sensitivity to gamma irradiation. The sensitivity of peripheral T lymphocytes from the PNP-deficient patient and normal controls to gamma irradiation and their proliferation was investigated after stimulation by phytohemagglutinin. Exogenous IL-2 was added to all cultures, as PNP-deficient T cells have decreased mitogenic responses in the absence of IL-2 (15). Similar to PNP-deficient bone marrow stroma cells, peripheral T lymphocytes from the patient were more sensitive to gamma irradiation (90% reduction at 500 cG) than those from a normal control (970 cG). Results are representative of three experiments.
To assess the sensitivity of bone marrow stroma to gamma irradiation, marrow stromal layers from the PNP-deficient patient and normal controls were established. After four cycles of subculturing, stromal layers were gamma irradiated at various doses, and assayed by MTT-based colorimetric method. Marrow from PNP-deficient patient was more sensitive to gamma irradiation (66% reduction at 500 cG) than normal bone marrow stroma cells (0% reduction at 500 cG) (Fig. 3) .
PNP enzyme activity. To confirm that the above stromal cell defect is indeed related to the patient's genetic defect, PNP enzymatic activity in the marrow stroma of the patient and normal controls was assessed. Similar to absent PNP enzyme activity in peripheral lymphocytes (data not shown), PNP enzymatic activity in the bone marrow stroma cell derived from the PNP-deficient patient was undetectable, in contrast to bone marrow derived from normal controls.
DISCUSSION
The present case demonstrated severe trilineage morphologic dysplasia of marrow cells in a patient with PNP deficiency. Dyserythropoiesis was particularly marked, and electron microscopic examination showed dysplastic changes in the erythroid lineage comparable in severity to those observed in congenital dyserythropoietic anemia. After developing marrow dysfunction the patient course was characterized by successive complications, including deep venous thrombosis, prolonged herpes zoster infection, and fatal intracranial hemorrhage.
A major question in the present case is whether the marrow dysfunction is directly related to the inherited genetic background, namely PNP deficiency and accumulation of toxic purine metabolites, or to an acquired factor. Indeed, purine metabolites were reported to be associated with dysplastic marrow morphology. For example Orchard et al. (24) found frequent marrow dysplasia in patients treated with the purine analogue, fludarabine. They speculated that a number of key enzymes, including DNA polymerase alpha, DNA primase, DNA ligase, and ribonucleotide reductase, might be impaired, thus contributing to the dysplastic changes. Further, cases of PNP deficiency associated with megaloblastic and dysplastic marrows have previously been reported (19, 20) . All the above support the notion that the severe marrow changes in the present case might be directly caused by the accumulation of deoxyguanosine and other metabolites in PNP deficiency. If this was the mechanism of the marrow dysplasia in our patient, then providing exogenous PNP should improve or reverse the process (25) . Indeed, repeat transfusion of red blood cells improved marrow morphology in our patient.
Marrow-directed autoimmunity is occasionally seen in systemic autoimmune disorders (26 -33) . However, no evidence for autoantibody production could be demonstrated in the present case. As previously mentioned, drug-and viral-induced dysplasia are also unlikely to play a role in the pathophysiology of the disorder in the present case. Specifically, although the patient had parvovirus infection at the age of 26 mo, this resolved completely, and at the stage of the marrow dysplasia (8 y of age), PCR of genomic DNA from marrow cells using specific primers for the parvovirus VP1 gene was negative. Although childhood myelodysplastic syndromes are frequently associated with an underlying genetic predisposition (34) , it is unlikely that the patient developed true premalignant myelodysplastic syndrome. High frequencies of neoplastic diseases have been described in PNP deficiency (2, 35) , but these are usually lymphoid and not myeloid. Further, the normal marrow cellularity, colony growth, cluster-to-colony ratio, marrow cell apoptosis rates, marrow cell Fas expression, and the improvement in marrow morphology after red cell transfusion are all uncharacteristic of a preleukemic myelodysplastic syndrome.
Increased sensitivity of PNP-deficient thymocytes to gamma-irradiation has been described in animal models (5) . We demonstrate for the first time that peripheral T lymphocytes from a patient with PNP are also highly sensitive to irradiation. This can be related to imbalance of dNTP that has been shown to interfere with DNA repair. Environmental factors including radiotherapy are known to induce DNA damage and myelodysplasia (36) . Thus, radiosensitivity, which is a feature of certain syndromes with a predisposition to myelodysplastic syndromes (e.g. Fanconi's anemia and Bloom's syndrome), might be a contributory factor in the development of the dysplasia in this patient.
Radiosensitivity of lymphocytes has been described in several immunodeficiencies such as ataxia telangiectasia, Nijme- gen breakage syndrome, and adenosine deaminase deficiency (37) . The decreased stromal cell viability in response to irradiation is consistent with the previous findings in PNPdeficient thymocytes (5) . Marrow stromal abnormalities were described in de novo myelodysplastic syndrome and in Shwachman-Diamond syndrome, a preleukemic inherited marrow failure syndrome (21) . Further studies are necessary to determine the relationship between the marrow stromal defect and the morphologic dysplasia and cytopenia.
